title: Isolation and characterization of human monoclonal antibodies to digoxin.
abstract: Fab preparations of sheep polyclonal anti-digoxin Abs have proven useful for reversal of the toxic effects of digoxin overdoses in patients. Unfortunately, the use of foreign species proteins in humans is limited because of the potential for immunological responses that include hypersensitivity reactions and acute anaphylaxis. Immunization of recently developed transgenic mice, whose endogenous micro heavy and kappa light chain Ig genes are inactivated and which carry human Ig gene segments, with a digoxin-protein conjugate has enabled us to generate and isolate eight hybridoma cell lines secreting human sequence anti-digoxin mAbs. Six of the mAbs have been partially characterized and shown to have high specificity and low nanomolar affinities for digoxin. In addition, detailed competition binding studies performed with three of these mAbs have shown them to have distinct differences in their digoxin binding, and that all three structural moieties of the drug, the primary digitoxose sugar, steroid, and five-member unsaturated lactone ring, contribute to Ab recognition.
authors.affiliation: Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, OH 45267, USA. william.ball@uc.edu
authors.forename: W J
authors.initials: WJ
authors.lastname: Ball
authors.forename: R
authors.initials: R
authors.lastname: Kasturi
authors.forename: P
authors.initials: P
authors.lastname: Dey
authors.forename: M
authors.initials: M
authors.lastname: Tabet
authors.forename: S
authors.initials: S
authors.lastname: O'Donnell
authors.forename: D
authors.initials: D
authors.lastname: Hudson
authors.forename: D
authors.initials: D
authors.lastname: Fishwild
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000737:chemistry* / Q000302:isolation & purification* / Q000378:metabolism; D000915:Antibody Affinity / Q000235:genetics; D001666:Binding Sites, Antibody / Q000235:genetics; D001667:Binding, Competitive / Q000235:genetics / Q000276:immunology; D004077:Digoxin / Q000008:administration & dosage / Q000276:immunology* / Q000378:metabolism; D006241:Haptens / Q000276:immunology; D006801:Humans; D006825:Hybridomas / Q000378:metabolism; D007074:Immunoglobulin G / Q000096:biosynthesis; D007135:Immunoglobulin Variable Region / Q000096:biosynthesis; D007274:Injections, Intraperitoneal; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D013045:Species Specificity
chemical_list: D000911:Antibodies, Monoclonal; D006241:Haptens; D007074:Immunoglobulin G; D007135:Immunoglobulin Variable Region; D004077:Digoxin